Holen Sie sich die Stockscreener-App
161.24
2.40%
3.78
Handel nachbörslich:
160.01
-1.23
-0.76%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$157.46
Offen:
$159.99
24-Stunden-Volumen:
7.29M
Relative Volume:
0.63
Marktkapitalisierung:
$203.33B
Einnahmen:
$19.59B
Nettoeinkommen (Verlust:
$5.81B
KGV:
35.53
EPS:
4.538
Netto-Cashflow:
$5.55B
1W Leistung:
+2.77%
1M Leistung:
+10.58%
6M Leistung:
+116.37%
1J Leistung:
+115.56%
1-Tages-Spanne:
$159.00
$162.24
1-Wochen-Bereich:
$154.28
$165.22
52-Wochen-Spanne:
$56.32
$165.22
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
161.24 | 197.77B | 19.59B | 5.81B | 5.55B | 4.538 |
|
ASML
Asml Holding Nv
|
1,066.82 | 411.14B | 35.54B | 10.43B | 9.71B | 26.71 |
|
AMAT
Applied Materials Inc
|
237.71 | 185.70B | 28.61B | 6.83B | 5.82B | 8.3875 |
|
KLAC
Kla Corp
|
1,219.14 | 158.82B | 12.52B | 4.24B | 3.87B | 31.85 |
|
TER
Teradyne Inc
|
183.07 | 28.47B | 2.83B | 469.17M | 568.90M | 2.8828 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Lam Research (NASDAQ:LRCX) Shares Up 2.4%Here's What Happened - MarketBeat
Lam Research Corporation stock volume spike explained2025 Year in Review & Fast Entry and Exit Trade Plans - newser.com
Bank of New York Mellon Corp Reduces Stake in Lam Research Corporation $LRCX - MarketBeat
Intellectus Partners LLC Buys New Shares in Lam Research Corporation $LRCX - MarketBeat
Texas Bank & Trust Co Takes Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Bought by Burney Co. - MarketBeat
Harel Insurance Investments & Financial Services Ltd. Buys 7,304 Shares of Lam Research Corporation $LRCX - MarketBeat
Mesirow Financial Investment Management Inc. Takes $234,000 Position in Lam Research Corporation $LRCX - MarketBeat
Why Lam Research Corporation stock is favored by pension funds2025 Big Picture & Long-Term Capital Growth Ideas - newser.com
This Artificial Intelligence (AI) Chip Stock Has Crushed Nvidia and Broadcom This Year. It Can Still Soar Higher. - The Motley Fool
Zweig DiMenna Associates LLC Buys Shares of 62,672 Lam Research Corporation $LRCX - MarketBeat
SS&H Financial Advisors Inc. Lowers Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Bought by World Investment Advisors - MarketBeat
Mccarter Private Wealth Services LLC Purchases Shares of 2,500 Lam Research Corporation $LRCX - MarketBeat
Bay Colony Advisory Group Inc d b a Bay Colony Advisors Takes $436,000 Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Atria Investments Inc - MarketBeat
Can Lam Research Sustain $5B-Plus Revenue Streak on Foundry Strength? - MSN
Murphy Pohlad Asset Management LLC Takes $205,000 Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Stock Holdings Lifted by Earned Wealth Advisors LLC - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Pinnacle Associates Ltd. - MarketBeat
Creekmur Asset Management LLC Has $1.13 Million Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Daymark Wealth Partners LLC - MarketBeat
Is Lam Research Corporation stock ready for a breakoutWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Lam Research Corp's Strong FCF Margins From AI-Related Chip Equipment Sales Shows LRCX Stock is Cheap - MSN
Lam Research Corporation $LRCX Shares Bought by Buckhead Capital Management LLC - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Strs Ohio - MarketBeat
Amalgamated Bank Has $27.09 Million Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Bessemer Group Inc. Sells 6,671 Shares of Lam Research Corporation $LRCX - MarketBeat
# Lam Research’s SWOT analysis: semiconductor giant rides AI wave amid stock valuation concerns - Investing.com
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Lam Research put volume heavy and directionally bearish - TipRanks
Should Lam Research Stock Be in Your Portfolio Post Solid Q1 Earnings? - sharewise.com
Ava Harter, chief legal officer of Lam Research, sells $1.41 million in LRCX stock - Investing.com India
Insider Selling: Lam Research (NASDAQ:LRCX) Insider Sells 9,010 Shares of Stock - MarketBeat
Ava Harter, chief legal officer of Lam Research, sells $1.41 million in LRCX stock By Investing.com - Investing.com South Africa
LAM Research Corp Executive Sells Over $1.4 Million in Company Stock - TradingView
LRCX insider trades: option exercise 6,010; sales at $157.46–$157.48 - Stock Titan
Lam Research Corporation (LRCX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Private Wealth Partners LLC Acquires New Holdings in Lam Research Corporation $LRCX - MarketBeat
Motley Fool Asset Management LLC Acquires 10,347 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Holdings Raised by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
Zacks.com featured highlights include Vertiv, Taiwan Semiconductor, Oracle, Lam Research and Elbit Systems - Yahoo Finance
Lam Research Corp. Stock Climbs 3.4%, Outperforms Peers - 富途牛牛
Focus Partners Advisor Solutions LLC Sells 1,965 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ:LRCX) Stock Price Up 3.4% on Analyst Upgrade - MarketBeat
Lam Research stock hits all-time high at 156.01 USD By Investing.com - Investing.com Nigeria
Lam Research: Dual Engines Of Growth Make It Worth Buying On Pullbacks (NASDAQ:LRCX) - Seeking Alpha
Lam Research Corp (LRCX)'s Winning Formula: Financial Metrics an - GuruFocus
Lam Research and Helen of Troy have been highlighted as Zacks Bull and Bear of the Day - sharewise.com
Lam Research (NASDAQ:LRCX) Price Target Raised to $184.20 - MarketBeat
Lam Research stock hits all-time high at 156.01 USD - Investing.com
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.98%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):